TNFRSF11B and osteoporosis: A meta-analysis conducted in 2022 by Han et al., taking into account all studies conducted to date, also found no effect of the osteoprotegerin rs3134070 polymorphism on the incidence of osteoporosis, which is in line with the conclusions drawn from this study [10].